Literature DB >> 16368258

Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.

Spiridon Papapetropoulos1, Donald S McCorquodale, Jocely Gonzalez, Lucie Jean-Gilles, Deborah C Mash.   

Abstract

Visual hallucinations (VH) are among the most common non-motor complications of Parkinson's disease (PD). A few studies on their etiopathogenesis have suggested involvement of cortical and amygdalar areas. In order to investigate the possible association between extranigral Lewy Body (LB) distribution across cortical and amygdalar regions and the presence of VH in PD brain donors, we conducted a clinico-pathological comparison of 10 PD patients with VH vs 10 closely matched PD patients without VH. The LB burden was significantly higher across the amygdala and the frontal, temporal and parietal cortical areas in patients with VH. Although our results suggest significant extranigral involvement, the precise etiopathologic mechanisms responsible for the development of VH need further clarification.

Entities:  

Mesh:

Year:  2005        PMID: 16368258     DOI: 10.1016/j.parkreldis.2005.10.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  20 in total

1.  Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Authors:  Sandra A Jacobson; Trisha Morshed; Brittany N Dugger; Thomas G Beach; Joseph G Hentz; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Christine M Belden; Lucia I Sue; John N Caviness; Chengcheng Hu
Journal:  Parkinsonism Relat Disord       Date:  2014-06-28       Impact factor: 4.891

Review 2.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

Review 3.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

4.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

5.  Parkinson's disease showing progressive conduction aphasia.

Authors:  Kenji Sakai; Kenjiro Ono; Hiromi Harada; Keisuke Shima; Masako Notoya; Masahito Yamada
Journal:  Neurol Sci       Date:  2011-08-31       Impact factor: 3.307

6.  Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology.

Authors:  George Naasan; Tal Shany-Ur; Manu Sidhu; Cynthia Barton; Robin Ketelle; Suzanne M Shdo; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neurocase       Date:  2019-04-22       Impact factor: 0.881

Review 7.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

9.  Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Authors:  Carmen Gasca-Salas; Pedro Clavero; David García-García; José A Obeso; María C Rodríguez-Oroz
Journal:  Hum Brain Mapp       Date:  2015-12-14       Impact factor: 5.038

Review 10.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.